4.4 Article

The SUMO protease SENP6 is a direct regulator of PML nuclear bodies

Journal

MOLECULAR BIOLOGY OF THE CELL
Volume 22, Issue 1, Pages 78-90

Publisher

AMER SOC CELL BIOLOGY
DOI: 10.1091/mbc.E10-06-0504

Keywords

-

Categories

Funding

  1. Scottish University Life Sciences Alliance
  2. Cancer Research UK
  3. Biotechnology and Biological Sciences Research Council (BBSRC)
  4. Biotechnology and Biological Sciences Research Council [BB/F010125/1] Funding Source: researchfish
  5. BBSRC [BB/F010125/1] Funding Source: UKRI

Ask authors/readers for more resources

Promyelocytic leukemia protein (PML) is the core component of PML-nuclear bodies (PML NBs). The small ubiquitin-like modifier (SUMO) system (and, in particular, SUMOylation of PML) is a critical component in the formation and regulation of PML NBs. SUMO protease SENP6 has been shown previously to be specific for SUMO-2/3-modified substrates and shows preference for SUMO polymers. Here, we further investigate the substrate specificity of SENP6 and show that it is also capable of cleaving mixed chains of SUMO-1 and SUMO-2/3. Depletion of SENP6 results in accumulation of endogenous SUMO-2/3 and SUMO-1 conjugates, and immunofluorescence analysis shows accumulation of SUMO and PML in an increased number of PML NBs. Although SENP6 depletion drastically increases the size of PML NBs, the organizational structure of the body is not affected. Mutation of the catalytic cysteine of SENP6 results in its accumulation in PML NBs, and biochemical analysis indicates that SUMO-modified PML is a substrate of SENP6.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available